Immunic, Inc.IMUXNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank93
3Y CAGR-4.8%
5Y CAGR+16.1%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
-4.8%/yr
vs +32.8%/yr prior
5Y CAGR
+16.1%/yr
Recent deceleration
Acceleration
-37.6pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
2.1x
Strong expansion
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$103.23M+5.3%
2024$98.05M-1.2%
2023$99.22M-17.0%
2022$119.49M+30.4%
2021$91.67M+87.2%
2020$48.97M+32.2%
2019$37.03M-3.6%
2018$38.41M-27.1%
2017$52.66M+27.6%
2016$41.27M-